Robert Z. Orlowski
@myeloma_doc
Deputy Chair of Lymphoma/Myeloma, Vice Chair MM Research @ MD Anderson; Translational researcher who hates myeloma. Tweets are my own. Retweets ≠ endorsements.
ID: 187354183
https://orcid.org/0000-0002-5723-4129 06-09-2010 00:32:59
41,41K Tweet
15,15K Takipçi
4,4K Takip Edilen
#Myeloma Paper of the Day: Phase 3 IRAKLIA study shows Isatuximab (+Pom/dex) w/ on-body delivery system shows similar efficacy & pharmacokinetic non-inferiority versus Isa-iv/Pom/dex w/ no unexpected safety signal and lower infusion reaction rate: pubmed.ncbi.nlm.nih.gov/40459178/. #mmsm
